Cargando…

1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer

Introduction: The aim of our study was to evaluate the efficacy and toxicity of a daily adaptive MR-guided SBRT on 1.5 T MR-linac in patients affected by lymph node oligometastases from PCa. Materials and Methods: The present study is a prospective observational study conducted in a single instituti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nicosia, Luca, Trapani, Giovanna, Rigo, Michele, Giaj-Levra, Niccolò, Mazzola, Rosario, Pastorello, Edoardo, Ricchetti, Francesco, Cuccia, Francesco, Figlia, Vanessa, Fiorini, Matilde, Alongi, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697920/ https://www.ncbi.nlm.nih.gov/pubmed/36431135 http://dx.doi.org/10.3390/jcm11226658

Ejemplares similares

PSMA-PET/CT-Based Stereotactic Body Radiotherapy (SBRT) in the Treatment of Uncomplicated Non-Spinal Bone Oligometastases from Prostate Cancer
por: Pastorello, Edoardo, et al.
Publicado: (2023)

1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients
por: Alongi, Filippo, et al.
Publicado: (2022)

1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment
por: Alongi, Filippo, et al.
Publicado: (2020)

1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical Outcomes
por: Cuccia, Francesco, et al.
Publicado: (2022)

Reduction of inter-observer differences in the delineation of the target in spinal metastases SBRT using an automatic contouring dedicated system
por: Giaj-Levra, Niccolò, et al.
Publicado: (2021)

Hypofractionated Postoperative Radiotherapy in Prostate Cancer with Ialuril Soft Gels(®): Toxicity and Efficacy Analysis on a Retrospective Series of 305 Patients
por: Nicosia, Luca, et al.
Publicado: (2022)

Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy
por: Cuccia, Francesco, et al.
Publicado: (2020)

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac
por: Naccarato, Stefania, et al.
Publicado: (2022)

Vas deferens metastasis from prostate adenocarcinoma treated with daily-adaptive MR-guided SBRT on 1.5T MR-linac
por: Vitale, Claudio, et al.
Publicado: (2022)

Repeated stereotactic radiosurgery for the treatment of relapsed brain metastases: is it time to give up whole-brain radiotherapy?
por: Nicosia, Luca, et al.
Publicado: (2020)

Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system
por: Giaj-Levra, Niccolò, et al.
Publicado: (2019)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
por: Mazzola, Rosario, et al.
Publicado: (2019)

Intra-fraction and Inter-fraction analysis of a dedicated immobilization device for intracranial radiation treatment
por: Ong, Chin Loon, et al.
Publicado: (2020)

Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia
por: Molon, Giulio, et al.
Publicado: (2022)

The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond
por: Onderdonk, Benjamin E., et al.
Publicado: (2019)

Stereotactic radiotherapy for oligometastases in the lymph nodes
por: Pasqualetti, Francesco, et al.
Publicado: (2022)

Stereotactic radiosurgery for the treatment of brainstem metastases: a multicenter retrospective study
por: Nicosia, Luca, et al.
Publicado: (2022)

MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer
por: Cuccia, Francesco, et al.
Publicado: (2021)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
por: Habl, Gregor, et al.
Publicado: (2017)

Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis
por: Gobbini, Elisa, et al.
Publicado: (2021)

Reply to Ghaffari et al. “In regard to Cuccia et al.: impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.”
por: Cuccia, Francesco, et al.
Publicado: (2020)

Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases
por: Pierret, Thomas, et al.
Publicado: (2022)

Activity of sotorasib against brain metastases from NSCLC harboring KRAS p.G12C mutation: a case report
por: Inno, Alessandro, et al.
Publicado: (2023)

Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution’s experience
por: Chai, Guangjin, et al.
Publicado: (2020)

Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique
por: Ruggieri, Ruggero, et al.
Publicado: (2018)

Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases
por: Sogono, Paolo, et al.
Publicado: (2021)

Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China
por: Xu, Chenyang, et al.
Publicado: (2022)

Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer
por: Gawish, Ahmed, et al.
Publicado: (2022)

Patient positioning and immobilization procedures for hybrid MR-Linac systems
por: Cuccia, Francesco, et al.
Publicado: (2021)

The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases
por: Andratschke, N., et al.
Publicado: (2018)

Correction to: Metabolic response after 68 Ga‑PSMA‑PET/CT‑directed IGRT/SBRT for oligometastases prostate cancer
por: Gawish, Ahmed, et al.
Publicado: (2023)

Stereotactic radiotherapy for bone oligometastases
por: Colosimo, Caterina, et al.
Publicado: (2022)

MR‐linac is the best modality for lung SBRT
por: Godley, Andrew, et al.
Publicado: (2019)

Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases†
por: Yamashita, Hideomi, et al.
Publicado: (2016)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022)

Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)

Stereotactic radiotherapy for brain oligometastases
por: Lupattelli, Marco, et al.
Publicado: (2022)

Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer
por: Schaule, J., et al.
Publicado: (2021)

ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial
por: Zilli, Thomas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r7ojdu4o0ncalrgnt77jf0sn13